Published in J Neurosci on January 13, 2010
TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration. Hum Mol Genet (2010) 5.75
TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy. J Neuropathol Exp Neurol (2010) 4.48
The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease. Brain Res (2012) 3.00
Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration. Nat Rev Neurosci (2011) 2.84
Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules. Hum Mol Genet (2010) 2.75
Molecular determinants and genetic modifiers of aggregation and toxicity for the ALS disease protein FUS/TLS. PLoS Biol (2011) 2.70
A yeast functional screen predicts new candidate ALS disease genes. Proc Natl Acad Sci U S A (2011) 2.68
Chronic traumatic encephalopathy: a potential late effect of sport-related concussive and subconcussive head trauma. Clin Sports Med (2011) 2.60
Tar DNA binding protein-43 (TDP-43) associates with stress granules: analysis of cultured cells and pathological brain tissue. PLoS One (2010) 2.49
Prion-like disorders: blurring the divide between transmissibility and infectivity. J Cell Sci (2010) 2.29
Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability. Proc Natl Acad Sci U S A (2012) 2.14
TDP-43 mediates degeneration in a novel Drosophila model of disease caused by mutations in VCP/p97. J Neurosci (2010) 2.05
Therapeutic modulation of eIF2α phosphorylation rescues TDP-43 toxicity in amyotrophic lateral sclerosis disease models. Nat Genet (2013) 1.63
Axonal transport of TDP-43 mRNA granules is impaired by ALS-causing mutations. Neuron (2014) 1.63
Evaluating the role of the FUS/TLS-related gene EWSR1 in amyotrophic lateral sclerosis. Hum Mol Genet (2012) 1.62
TDP-43-mediated neuron loss in vivo requires RNA-binding activity. PLoS One (2010) 1.58
An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity. Nat Struct Mol Biol (2011) 1.58
Astrocyte pathology and the absence of non-cell autonomy in an induced pluripotent stem cell model of TDP-43 proteinopathy. Proc Natl Acad Sci U S A (2013) 1.49
FUS and TARDBP but not SOD1 interact in genetic models of amyotrophic lateral sclerosis. PLoS Genet (2011) 1.46
Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models. Nat Chem Biol (2014) 1.43
Requirements for stress granule recruitment of fused in sarcoma (FUS) and TAR DNA-binding protein of 43 kDa (TDP-43). J Biol Chem (2012) 1.43
Neurodegeneration the RNA way. Prog Neurobiol (2011) 1.43
Aberrant localization of FUS and TDP43 is associated with misfolding of SOD1 in amyotrophic lateral sclerosis. PLoS One (2012) 1.42
Phosphorylation promotes neurotoxicity in a Caenorhabditis elegans model of TDP-43 proteinopathy. J Neurosci (2010) 1.41
RNA-binding proteins with prion-like domains in ALS and FTLD-U. Prion (2011) 1.40
Progranulin deficiency promotes neuroinflammation and neuron loss following toxin-induced injury. J Clin Invest (2012) 1.34
Autoregulation of TDP-43 mRNA levels involves interplay between transcription, splicing, and alternative polyA site selection. Genes Dev (2012) 1.33
Protein aggregation in amyotrophic lateral sclerosis. Acta Neuropathol (2013) 1.32
The C-terminal TDP-43 fragments have a high aggregation propensity and harm neurons by a dominant-negative mechanism. PLoS One (2010) 1.32
Inhibition of RNA lariat debranching enzyme suppresses TDP-43 toxicity in ALS disease models. Nat Genet (2012) 1.31
A cellular model for sporadic ALS using patient-derived induced pluripotent stem cells. Mol Cell Neurosci (2013) 1.25
The ALS disease protein TDP-43 is actively transported in motor neuron axons and regulates axon outgrowth. Hum Mol Genet (2012) 1.25
Pathological mechanisms underlying TDP-43 driven neurodegeneration in FTLD-ALS spectrum disorders. Hum Mol Genet (2013) 1.21
TDP-43 neurotoxicity and protein aggregation modulated by heat shock factor and insulin/IGF-1 signaling. Hum Mol Genet (2011) 1.19
Wild-type and A315T mutant TDP-43 exert differential neurotoxicity in a Drosophila model of ALS. Hum Mol Genet (2011) 1.18
Expansive gene transfer in the rat CNS rapidly produces amyotrophic lateral sclerosis relevant sequelae when TDP-43 is overexpressed. Mol Ther (2010) 1.16
TDP-43 Proteinopathy and ALS: Insights into Disease Mechanisms and Therapeutic Targets. Neurotherapeutics (2015) 1.15
The ALS disease-associated mutant TDP-43 impairs mitochondrial dynamics and function in motor neurons. Hum Mol Genet (2013) 1.11
ALS-associated ataxin 2 polyQ expansions enhance stress-induced caspase 3 activation and increase TDP-43 pathological modifications. J Neurosci (2012) 1.09
TDP-43: the relationship between protein aggregation and neurodegeneration in amyotrophic lateral sclerosis and frontotemporal lobar degeneration. FEBS J (2011) 1.09
Profilin 1 associates with stress granules and ALS-linked mutations alter stress granule dynamics. J Neurosci (2014) 1.09
RNA processing pathways in amyotrophic lateral sclerosis. Neurogenetics (2010) 1.08
Prion-like domains as epigenetic regulators, scaffolds for subcellular organization, and drivers of neurodegenerative disease. Brain Res (2016) 1.08
Mutant LRRK2 toxicity in neurons depends on LRRK2 levels and synuclein but not kinase activity or inclusion bodies. J Neurosci (2014) 1.08
Partial loss of TDP-43 function causes phenotypes of amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A (2014) 1.08
RNA-mediated toxicity in neurodegenerative disease. Mol Cell Neurosci (2012) 1.07
Proteostasis and movement disorders: Parkinson's disease and amyotrophic lateral sclerosis. Cold Spring Harb Perspect Biol (2011) 1.02
The dual functions of the extreme N-terminus of TDP-43 in regulating its biological activity and inclusion formation. Hum Mol Genet (2013) 1.02
Accelerated disease onset with stabilized familial amyotrophic lateral sclerosis (ALS)-linked mutant TDP-43 proteins. J Biol Chem (2012) 1.02
Does a loss of TDP-43 function cause neurodegeneration? Mol Neurodegener (2012) 1.02
Hyperphosphorylation as a defense mechanism to reduce TDP-43 aggregation. PLoS One (2011) 1.00
ALS-linked mutations enlarge TDP-43-enriched neuronal RNA granules in the dendritic arbor. J Neurosci (2014) 1.00
Mechanisms of disease in frontotemporal lobar degeneration: gain of function versus loss of function effects. Acta Neuropathol (2012) 0.99
TDP-1/TDP-43 regulates stress signaling and age-dependent proteotoxicity in Caenorhabditis elegans. PLoS Genet (2012) 0.97
The inhibition of TDP-43 mitochondrial localization blocks its neuronal toxicity. Nat Med (2016) 0.94
Structural transformation of the amyloidogenic core region of TDP-43 protein initiates its aggregation and cytoplasmic inclusion. J Biol Chem (2013) 0.92
Selective forelimb impairment in rats expressing a pathological TDP-43 25 kDa C-terminal fragment to mimic amyotrophic lateral sclerosis. Mol Ther (2013) 0.92
TDP-43 toxicity in yeast. Methods (2010) 0.91
A fruitful endeavor: modeling ALS in the fruit fly. Brain Res (2014) 0.91
The heat shock response plays an important role in TDP-43 clearance: evidence for dysfunction in amyotrophic lateral sclerosis. Brain (2016) 0.91
Progranulin and TDP-43: mechanistic links and future directions. J Mol Neurosci (2011) 0.90
High-throughput screening in primary neurons. Methods Enzymol (2012) 0.90
Interplay of endoplasmic reticulum stress and autophagy in neurodegenerative disorders. Autophagy (2016) 0.88
Genetic strategies to study TDP-43 in rodents and to develop preclinical therapeutics for amyotrophic lateral sclerosis. Eur J Neurosci (2011) 0.88
Development of a novel nonradiometric assay for nucleic acid binding to TDP-43 suitable for high-throughput screening using AlphaScreen technology. J Biomol Screen (2010) 0.87
Rodent models of TDP-43 proteinopathy: investigating the mechanisms of TDP-43-mediated neurodegeneration. J Mol Neurosci (2011) 0.87
Potential mechanisms of progranulin-deficient FTLD. J Mol Neurosci (2011) 0.86
A high-content screen identifies novel compounds that inhibit stress-induced TDP-43 cellular aggregation and associated cytotoxicity. J Biomol Screen (2013) 0.86
Genetics of dementia. Semin Neurol (2012) 0.86
Early retinal neurodegeneration and impaired Ran-mediated nuclear import of TDP-43 in progranulin-deficient FTLD. J Exp Med (2014) 0.86
Invited review: decoding the pathophysiological mechanisms that underlie RNA dysregulation in neurodegenerative disorders: a review of the current state of the art. Neuropathol Appl Neurobiol (2015) 0.85
Widespread aggregation of mutant VAPB associated with ALS does not cause motor neuron degeneration or modulate mutant SOD1 aggregation and toxicity in mice. Mol Neurodegener (2013) 0.85
TARDBP mutation analysis in TDP-43 proteinopathies and deciphering the toxicity of mutant TDP-43. J Alzheimers Dis (2013) 0.85
An acetylation switch controls TDP-43 function and aggregation propensity. Nat Commun (2015) 0.85
Preservation of forelimb function by UPF1 gene therapy in a rat model of TDP-43-induced motor paralysis. Gene Ther (2014) 0.84
Oxr1 improves pathogenic cellular features of ALS-associated FUS and TDP-43 mutations. Hum Mol Genet (2015) 0.84
Linking RNA Dysfunction and Neurodegeneration in Amyotrophic Lateral Sclerosis. Neurotherapeutics (2015) 0.83
An ALS-mutant TDP-43 neurotoxic peptide adopts an anti-parallel β-structure and induces TDP-43 redistribution. Hum Mol Genet (2014) 0.83
Amelioration of toxicity in neuronal models of amyotrophic lateral sclerosis by hUPF1. Proc Natl Acad Sci U S A (2015) 0.82
Divergent phenotypes in mutant TDP-43 transgenic mice highlight potential confounds in TDP-43 transgenic modeling. PLoS One (2014) 0.82
Motor-Coordinative and Cognitive Dysfunction Caused by Mutant TDP-43 Could Be Reversed by Inhibiting Its Mitochondrial Localization. Mol Ther (2017) 0.81
Regulation of nuclear TDP-43 by NR2A-containing NMDA receptors and PTEN. J Cell Sci (2012) 0.80
High-content RNAi screening identifies the Type 1 inositol triphosphate receptor as a modifier of TDP-43 localization and neurotoxicity. Hum Mol Genet (2012) 0.80
Aggregation of human S100A8 and S100A9 amyloidogenic proteins perturbs proteostasis in a yeast model. PLoS One (2013) 0.80
Reducing TDP-43 aggregation does not prevent its cytotoxicity. Acta Neuropathol Commun (2013) 0.80
Dexpramipexole is ineffective in two models of ALS related neurodegeneration. PLoS One (2014) 0.79
TDP-43 identified from a genome wide RNAi screen for SOD1 regulators. PLoS One (2012) 0.78
Similar dose-dependence of motor neuron cell death caused by wild type human TDP-43 and mutants with ALS-associated amino acid substitutions. J Biomed Sci (2013) 0.78
Amino acid analog toxicity in primary rat neuronal and astrocyte cultures: implications for protein misfolding and TDP-43 regulation. J Neurosci Res (2011) 0.78
RNA-processing protein TDP-43 regulates FOXO-dependent protein quality control in stress response. PLoS Genet (2014) 0.78
Yeast genetic screen reveals novel therapeutic strategy for ALS. Rare Dis (2013) 0.78
A network of RNA and protein interactions in Fronto Temporal Dementia. Front Mol Neurosci (2015) 0.77
PRO-MINE: A bioinformatics repository and analytical tool for TARDBP mutations. Hum Mutat (2011) 0.77
Cell-based screening: extracting meaning from complex data. Neuron (2015) 0.77
Glia as primary drivers of neuropathology in TDP-43 proteinopathies. Proc Natl Acad Sci U S A (2013) 0.77
Modeling ALS and FTD with iPSC-derived neurons. Brain Res (2015) 0.77
The extreme N-terminus of TDP-43 mediates the cytoplasmic aggregation of TDP-43 and associated toxicity in vivo. Brain Res (2016) 0.76
Hypo- and Hyper-Assembly Diseases of RNA-Protein Complexes. Trends Mol Med (2016) 0.76
Characterization of β-domains in C-terminal fragments of TDP-43 by scanning tunneling microscopy. J Struct Biol (2012) 0.76
Nucleus Accumbens 1, a Pox virus and Zinc finger/Bric-a-brac Tramtrack Broad protein binds to TAR DNA-binding protein 43 and has a potential role in Amyotrophic Lateral Sclerosis. Neuroscience (2012) 0.76
Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science (2006) 27.96
TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science (2008) 14.09
Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science (2009) 13.45
Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature (2004) 11.82
TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun (2006) 10.69
TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet (2008) 9.51
Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell (1998) 7.13
TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis. Lancet Neurol (2008) 5.33
Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. J Virol (1995) 5.18
Rethinking ALS: the FUS about TDP-43. Cell (2009) 4.71
RNA-mediated neuromuscular disorders. Annu Rev Neurosci (2006) 4.24
Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease. Front Biosci (2008) 4.01
Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation. J Biol Chem (2008) 3.56
Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration. Neuron (2006) 3.51
A yeast TDP-43 proteinopathy model: Exploring the molecular determinants of TDP-43 aggregation and cellular toxicity. Proc Natl Acad Sci U S A (2008) 3.46
Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells. Proc Natl Acad Sci U S A (1999) 3.33
TDP-43 mutation in familial amyotrophic lateral sclerosis. Ann Neurol (2008) 2.92
TDP-43, the signature protein of FTLD-U, is a neuronal activity-responsive factor. J Neurochem (2007) 2.91
Structural determinants of the cellular localization and shuttling of TDP-43. J Cell Sci (2008) 2.79
TDP43 is a human low molecular weight neurofilament (hNFL) mRNA-binding protein. Mol Cell Neurosci (2007) 2.75
TARDBP mutations in motoneuron disease with frontotemporal lobar degeneration. Ann Neurol (2009) 2.30
TDP-43 proteinopathy: the neuropathology underlying major forms of sporadic and familial frontotemporal lobar degeneration and motor neuron disease. Acta Neuropathol (2007) 2.12
Characterization of an RNA granule from developing brain. Mol Cell Proteomics (2005) 2.07
Two German kindreds with familial amyotrophic lateral sclerosis due to TARDBP mutations. Arch Neurol (2008) 1.78
Automated microscope system for determining factors that predict neuronal fate. Proc Natl Acad Sci U S A (2005) 1.75
APOE epsilon2 is associated with intact cognition but increased Alzheimer pathology in the oldest old. Neurology (2009) 1.74
The serum response factor and a putative novel transcription factor regulate expression of the immediate-early gene Arc/Arg3.1 in neurons. J Neurosci (2009) 1.69
Functions of intermediate filaments in neuronal development and disease. J Neurobiol (2004) 1.63
Plaque-bearing mice with reduced levels of oligomeric amyloid-beta assemblies have intact memory function. Neuroscience (2007) 1.59
Targeted overexpression of human alpha-synuclein triggers microglial activation and an adaptive immune response in a mouse model of Parkinson disease. J Neuropathol Exp Neurol (2008) 1.45
Aggregates assembled from overexpression of wild-type alpha-synuclein are not toxic to human neuronal cells. J Neuropathol Exp Neurol (2008) 1.26
Single neuron ubiquitin-proteasome dynamics accompanying inclusion body formation in huntington disease. J Biol Chem (2008) 1.25
The molecular genetics and neuropathology of frontotemporal lobar degeneration: recent developments. Neurogenetics (2007) 1.20
Amyotrophic lateral sclerosis models and human neuropathology: similarities and differences. Acta Neuropathol (2007) 1.18
Splice variants of the NR1 subunit differentially induce NMDA receptor-dependent gene expression. J Neurosci (2006) 1.10
Racing against the clock: recognizing, differentiating, diagnosing, and referring the amyotrophic lateral sclerosis patient. Ann Neurol (2009) 1.02
Characterization of neuronal intermediate filament protein expression in cervical spinal motor neurons in sporadic amyotrophic lateral sclerosis (ALS). J Neuropathol Exp Neurol (2000) 0.99
TDP-43 inclusions do not protect motor neurons from sporadic ALS. Acta Neuropathol (2008) 0.96
Astrocytic protection of spinal motor neurons but not cortical neurons against loss of Als2/alsin function. Hum Mol Genet (2009) 0.87
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature (2004) 11.82
Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease. Neuron (2007) 6.60
Robo4 is a vascular-specific receptor that inhibits endothelial migration. Dev Biol (2003) 2.58
Tau reduction prevents Abeta-induced defects in axonal transport. Science (2010) 2.57
The IGF-1/Akt pathway is neuroprotective in Huntington's disease and involves Huntingtin phosphorylation by Akt. Dev Cell (2002) 2.56
Serines 13 and 16 are critical determinants of full-length human mutant huntingtin induced disease pathogenesis in HD mice. Neuron (2009) 2.43
A Drosophila model for TDP-43 proteinopathy. Proc Natl Acad Sci U S A (2010) 2.36
Identifying polyglutamine protein species in situ that best predict neurodegeneration. Nat Chem Biol (2011) 2.24
IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome. J Cell Biol (2009) 2.16
Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability. Proc Natl Acad Sci U S A (2012) 2.14
New neurons clear the path of astrocytic processes for their rapid migration in the adult brain. Neuron (2010) 2.12
A comprehensive glossary of autophagy-related molecules and processes (2nd edition). Autophagy (2011) 2.02
Direct membrane association drives mitochondrial fission by the Parkinson disease-associated protein alpha-synuclein. J Biol Chem (2011) 1.96
Slit proteins: molecular guidance cues for cells ranging from neurons to leukocytes. Curr Opin Genet Dev (2002) 1.77
Automated microscope system for determining factors that predict neuronal fate. Proc Natl Acad Sci U S A (2005) 1.75
AMPA receptors regulate transcription of the plasticity-related immediate-early gene Arc. Nat Neurosci (2006) 1.72
Role of the chemokine SDF-1 as the meningeal attractant for embryonic cerebellar neurons. Nat Neurosci (2002) 1.69
The serum response factor and a putative novel transcription factor regulate expression of the immediate-early gene Arc/Arg3.1 in neurons. J Neurosci (2009) 1.69
Arc in synaptic plasticity: from gene to behavior. Trends Neurosci (2011) 1.69
A small-molecule scaffold induces autophagy in primary neurons and protects against toxicity in a Huntington disease model. Proc Natl Acad Sci U S A (2010) 1.65
A genetic model for a central (septum transversum) congenital diaphragmatic hernia in mice lacking Slit3. Proc Natl Acad Sci U S A (2003) 1.60
NMDA and AMPA receptors: old channels, new tricks. Trends Neurosci (2007) 1.59
An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity. Nat Struct Mol Biol (2011) 1.58
DSCAM functions as a netrin receptor in commissural axon pathfinding. Proc Natl Acad Sci U S A (2009) 1.58
Proteostasis of polyglutamine varies among neurons and predicts neurodegeneration. Nat Chem Biol (2013) 1.52
Arc regulates spine morphology and maintains network stability in vivo. Proc Natl Acad Sci U S A (2010) 1.51
Astrocyte pathology and the absence of non-cell autonomy in an induced pluripotent stem cell model of TDP-43 proteinopathy. Proc Natl Acad Sci U S A (2013) 1.49
Protein aggregates in Huntington's disease. Exp Neurol (2011) 1.46
Cross-species translation of the Morris maze for Alzheimer's disease. J Clin Invest (2016) 1.43
Neuronal repellent Slit2 inhibits dendritic cell migration and the development of immune responses. J Immunol (2003) 1.35
Progranulin deficiency promotes neuroinflammation and neuron loss following toxin-induced injury. J Clin Invest (2012) 1.34
Rapid target-specific remodeling of fast-spiking inhibitory circuits after loss of dopamine. Neuron (2011) 1.34
Cytoplasmic retention of polyglutamine-expanded androgen receptor ameliorates disease via autophagy in a mouse model of spinal and bulbar muscular atrophy. Hum Mol Genet (2009) 1.32
Pre-mRNA splicing and retinitis pigmentosa. Mol Vis (2006) 1.32
Inhibition of RNA lariat debranching enzyme suppresses TDP-43 toxicity in ALS disease models. Nat Genet (2012) 1.31
Up-regulation of the proapoptotic caspase 2 splicing isoform by a candidate tumor suppressor, RBM5. Proc Natl Acad Sci U S A (2008) 1.28
Quantitative relationships between huntingtin levels, polyglutamine length, inclusion body formation, and neuronal death provide novel insight into huntington's disease molecular pathogenesis. J Neurosci (2010) 1.25
Single neuron ubiquitin-proteasome dynamics accompanying inclusion body formation in huntington disease. J Biol Chem (2008) 1.25
ALS-associated mutation FUS-R521C causes DNA damage and RNA splicing defects. J Clin Invest (2014) 1.23
Mutations in tau gene exon 10 associated with FTDP-17 alter the activity of an exonic splicing enhancer to interact with Tra2 beta. J Biol Chem (2003) 1.22
Stabilization of the tau exon 10 stem loop alters pre-mRNA splicing. J Biol Chem (2006) 1.22
Targeting neural precursors in the adult brain rescues injured dopamine neurons. Proc Natl Acad Sci U S A (2009) 1.21
Progranulin promotes neurite outgrowth and neuronal differentiation by regulating GSK-3β. Protein Cell (2010) 1.19
Transient decrease in F-actin may be necessary for translocation of proteins into dendritic spines. Eur J Neurosci (2005) 1.15
Regulated Fox-2 isoform expression mediates protein 4.1R splicing during erythroid differentiation. Blood (2007) 1.14
p130CAS is required for netrin signaling and commissural axon guidance. J Neurosci (2007) 1.14
RNA helicase p68 (DDX5) regulates tau exon 10 splicing by modulating a stem-loop structure at the 5' splice site. Mol Cell Biol (2011) 1.12
Comment on "Drug screening for ALS using patient-specific induced pluripotent stem cells". Sci Transl Med (2013) 1.11
Splice variants of the NR1 subunit differentially induce NMDA receptor-dependent gene expression. J Neurosci (2006) 1.10
Mutations in PRPF31 inhibit pre-mRNA splicing of rhodopsin gene and cause apoptosis of retinal cells. J Neurosci (2005) 1.09
RBM4 interacts with an intronic element and stimulates tau exon 10 inclusion. J Biol Chem (2006) 1.08
CPEB1 regulates beta-catenin mRNA translation and cell migration in astrocytes. Glia (2008) 1.08
Mutant LRRK2 toxicity in neurons depends on LRRK2 levels and synuclein but not kinase activity or inclusion bodies. J Neurosci (2014) 1.08
Cutting edge: bone morphogenetic protein antagonists Drm/Gremlin and Dan interact with Slits and act as negative regulators of monocyte chemotaxis. J Immunol (2004) 1.07
Modulation of inflammation by slit protein in vivo in experimental crescentic glomerulonephritis. Am J Pathol (2004) 1.07
Angiocrine factors modulate tumor proliferation and motility through EphA2 repression of Slit2 tumor suppressor function in endothelium. Cancer Res (2010) 1.07
MiR-124 regulates early neurogenesis in the optic vesicle and forebrain, targeting NeuroD1. Nucleic Acids Res (2010) 1.07
Polypyrimidine tract-binding protein (PTB) differentially affects malignancy in a cell line-dependent manner. J Biol Chem (2008) 1.07
Identification of novel potentially toxic oligomers formed in vitro from mammalian-derived expanded huntingtin exon-1 protein. J Biol Chem (2012) 1.07
Expression of human FUS/TLS in yeast leads to protein aggregation and cytotoxicity, recapitulating key features of FUS proteinopathy. Protein Cell (2011) 1.07
Expression of human FUS protein in Drosophila leads to progressive neurodegeneration. Protein Cell (2011) 1.06
A compact beta model of huntingtin toxicity. J Biol Chem (2011) 1.04
Arc in the nucleus regulates PML-dependent GluA1 transcription and homeostatic plasticity. Nat Neurosci (2013) 1.04
Deubiquitinating enzyme USP33/VDU1 is required for Slit signaling in inhibiting breast cancer cell migration. Proc Natl Acad Sci U S A (2009) 1.03
Protein turnover and inclusion body formation. Autophagy (2009) 1.03
Pathogenic TARDBP mutations in amyotrophic lateral sclerosis and frontotemporal dementia: disease-associated pathways. Rev Neurosci (2010) 1.03
Slit proteins, potential endogenous modulators of inflammation. J Neurovirol (2002) 1.02
Neuronal migration and molecular conservation with leukocyte chemotaxis. Genes Dev (2002) 1.02
Pathogenic cysteine mutations affect progranulin function and production of mature granulins. J Neurochem (2009) 1.01
Slit2 inhibits glioma cell invasion in the brain by suppression of Cdc42 activity. Neuro Oncol (2009) 1.01
Conformation sensors that distinguish monomeric proteins from oligomers in live cells. Chem Biol (2010) 1.00
Disease-associated polyglutamine stretches in monomeric huntingtin adopt a compact structure. J Mol Biol (2012) 0.99
Slit and robo: expression patterns in lung development. Gene Expr Patterns (2003) 0.98
Targeting H3K4 trimethylation in Huntington disease. Proc Natl Acad Sci U S A (2013) 0.98
Midline crossing and Slit responsiveness of commissural axons require USP33. Nat Neurosci (2009) 0.98
Crystallization and diffraction properties of the Fab fragment of 3B5H10, an antibody specific for disease-causing polyglutamine stretches. Acta Crystallogr Sect F Struct Biol Cryst Commun (2005) 0.97
An erythroid differentiation-specific splicing switch in protein 4.1R mediated by the interaction of SF2/ASF with an exonic splicing enhancer. Blood (2004) 0.97
Visualization of spatially and temporally regulated N-WASP activity during cytoskeletal reorganization in living cells. Proc Natl Acad Sci U S A (2004) 0.97
Identification of photoreceptor genes affected by PRPF31 mutations associated with autosomal dominant retinitis pigmentosa. Neurobiol Dis (2007) 0.95
Structure-guided inhibitor design expands the scope of analog-sensitive kinase technology. ACS Chem Biol (2013) 0.94
Axon guidance factor SLIT2 inhibits neural invasion and metastasis in pancreatic cancer. Cancer Res (2014) 0.94
Modeling Huntington's disease with induced pluripotent stem cells. Mol Cell Neurosci (2013) 0.94
PolyQ disease: too many Qs, too much function? Neuron (2010) 0.93
Prioritized research recommendations from the National Institute of Neurological Disorders and Stroke Parkinson's Disease 2014 conference. Ann Neurol (2014) 0.92
Methylene blue modulates huntingtin aggregation intermediates and is protective in Huntington's disease models. J Neurosci (2012) 0.92
Inclusions in frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP) and amyotrophic lateral sclerosis (ALS), but not FTLD with FUS proteinopathy (FTLD-FUS), have properties of amyloid. Acta Neuropathol (2013) 0.91
The role of miR-124a in early development of the Xenopus eye. Mech Dev (2009) 0.91
An evaluation of specificity in activity-dependent gene expression in neurons. Prog Neurobiol (2002) 0.90
Cooperative signaling between Slit2 and Ephrin-A1 regulates a balance between angiogenesis and angiostasis. Mol Cell Biol (2010) 0.90
High-content screening of primary neurons: ready for prime time. Curr Opin Neurobiol (2009) 0.90
High-throughput screening in primary neurons. Methods Enzymol (2012) 0.90
Slit modulates cerebrovascular inflammation and mediates neuroprotection against global cerebral ischemia. Exp Neurol (2007) 0.89
Distinguishing between directional guidance and motility regulation in neuronal migration. J Neurosci (2003) 0.89
Structural basis of Robo proline-rich motif recognition by the srGAP1 Src homology 3 domain in the Slit-Robo signaling pathway. J Biol Chem (2006) 0.89
Creation of an open-access, mutation-defined fibroblast resource for neurological disease research. PLoS One (2012) 0.88